Bart G.J. Knols's blog
The freely available book titled "Artemisia annua,Artemisinin, ACTs & Malaria Control in Africa: Tradition, Science and Public Policy", has been updated by the author, Dana Dalrymple, and has been expanded with an Annex (Annex 7), titled: "The Early Role of Novartis in ACT Development" (pp. 189-192).
The book is attached to this blog. We are grateful to Dr. Dalrymple to make this updated version available for free to MalariaWorld subscribers.
The MW team.
This year World Health Day has its focus on vector-borne diseases, including malaria. The World Health Organization has set specific goals for this day, and is asking the international community working on malaria and other vectors to pay special attention towards protection from vector-borne diseases.
As the Keystone symposium on the science of malaria eradication has come to an end, the one thing I regret is that I wasn't there to participate. It undoubtedly must have been an exciting meeting, which is clear from the messages we received from the MESA group (read them here).
The World Malaria Report for 2013 paints an optimistic picture when it reports a fifty percent reduction in global mortality due malaria since 2000. However, the same report states that in 2012, “in 41 of the 103 countries reporting, which account for 80% of estimated cases, it is not possible to reliably assess malaria trends using the data submitted to WHO” as “information systems are weakest, and the challenges for strengthening systems are greatest, where the malaria burden is greatest.”...